Summary Medicare has selected 15 drugs, including the popular diabetes and weight-loss drug semaglutide, for its second round of price negotiations under the Inflation Reduction Act. The negotiations aim to lower prescription drug costs for […]
Summary The Diabetes Technology Society (DTS) has introduced a new error grid to enhance the accuracy assessment of continuous glucose monitors (CGMs). This grid refines risk zones, incorporates CGM trend analysis, and offers a more […]
Summary Tirzepatide, a novel dual GIP and GLP-1 receptor agonist, has shown superior weight loss results compared to semaglutide in recent clinical trials. This breakthrough offers new hope for individuals struggling with obesity and its […]
Summary This article explores groundbreaking research that sheds light on the complex biological pathways associated with childhood obesity and metabolic dysfunction. By analyzing various biological data from over 800 European children, the study identifies distinct […]
Summary This pilot study reveals that a single session of moderate-intensity intradialytic aerobic exercise (IDE) can improve blood pressure control and reduce sleepiness after hemodialysis in patients with kidney failure. The research also demonstrates the […]
Summary Intermittent fasting (IF) is gaining popularity as a weight-loss method and for its potential benefits for cardiovascular health. While IF can lead to weight loss and improve some metabolic markers, recent studies suggest a […]
Summary Two groundbreaking therapies offer hope for insulin independence in diabetes, potentially transforming lives and reducing the burden of daily injections. One therapy utilizes gene editing to enable successful islet cell transplantation without immunosuppression. The […]
Summary Tirzepatide (Zepbound) is the first FDA-approved medication for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. Clinical trials have shown significant improvements in OSA symptoms and weight loss, offering a new therapeutic option […]
Summary This article explores the latest advancements in diabetes treatment, focusing on new drug options like SGLT2 inhibitors, GLP-1 receptor agonists, and tirzepatide. These medications offer improved blood sugar control, weight loss benefits, and even […]
Summary This article explores the latest advancements in diabetes management, focusing on new medication options like GLP-1 receptor agonists, SGLT-2 inhibitors, and Tirzepatide. It also discusses the role of technology, including continuous glucose monitors (CGMs) […]
© 2025 Newsguru LTD. All rights reserved.